Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Merck
Mallinckrodt
Baxter
Medtronic

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Amphastar Pharms Inc Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for AMPHASTAR PHARMS INC, and what generic and branded alternatives to AMPHASTAR PHARMS INC drugs are available?

AMPHASTAR PHARMS INC has eight approved drugs.



Summary for Amphastar Pharms Inc
US Patents:0
Tradenames:7
Ingredients:7
NDAs:8

Drugs and US Patents for Amphastar Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amphastar Pharms Inc NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 209933-001 Sep 25, 2017 AP RX No No   Start Trial   Start Trial
Amphastar Pharms Inc CORTROSYN cosyntropin INJECTABLE;INJECTION 016750-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial
Amphastar Pharms Inc ENOXAPARIN SODIUM enoxaparin sodium INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 208600-001 Mar 14, 2019 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Express Scripts
Merck
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.